Moreover, SOX2 affects cancer cell proliferation and survival by regulating cell cycle-related genes WEE1 and cyclin-dependent kinase 1 (CDK1), making PCa cells resistant to NHRSI treatment. This evidence concerns the gene CDK1 and cancer.